Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 415(3): 439-44, 2011 Nov 25.
Article in English | MEDLINE | ID: mdl-22051050

ABSTRACT

The use of non-integrating human artificial chromosomes (HACs) in gene therapy possibly allows for safe and reliable genetic modification of human cells without insertional mutagenesis and/or unexpected oncogene activations. Although we previously demonstrated that the HAC provides long-term therapeutic erythropoietin (EPO) production in normal human primary fibroblasts (hPFs), the expression level of EPO was too low to provide medical benefits for human therapy. Thus, the next challenge for the application of this system in therapeutic purposes is to improve the transgene expression on HACs. Here, we newly constructed chromosome 14-based HACs and examined the effects of the telomere and promoter regions on the expression level of the tansgene in hPFs. We showed that the use of natural telomere/sub-telomere and enhancers within the 5' untranslated region of the human ubiquitin C gene greatly increased (over 1000-fold) the EPO production in hPFs. Furthermore, we demonstrated the reprogramming of mouse embryonic fibroblasts by HAC-mediated introduction of four transcription factors, and established induced pluripotent stem cells with no trace of the HACs carrying multiple expression cassettes with large genome fragments. These results indicate that this HAC system could allow us to manipulate multiple transgenes efficiently in human primary cells, providing a promising tool not only for gene therapy but also for investigating genome functions in drug discoveries.


Subject(s)
Cellular Reprogramming , Chromosomes, Artificial, Human/genetics , Chromosomes, Human, Pair 14/genetics , Gene Transfer Techniques , Genetic Vectors , Transgenes , Animals , Cell Line , Enhancer Elements, Genetic/genetics , Erythropoietin/genetics , Fibroblasts , Gene Expression , Genetic Therapy , Humans , Induced Pluripotent Stem Cells/metabolism , Mice , Promoter Regions, Genetic/genetics , Telomere/genetics
2.
Biochem Biophys Res Commun ; 369(3): 807-11, 2008 May 09.
Article in English | MEDLINE | ID: mdl-18328257

ABSTRACT

Telomerase-mediated life-span extension enables the expansion of normal cells without malignant transformation, and thus has been thought to be useful in cell therapies. Currently, integrating vectors including the retrovirus are used for human telomerase reverse transcriptase (hTERT)-mediated expansion of normal cells; however, the use of these vectors potentially causes unexpected insertional mutagenesis and/or activation of oncogenes. Here, we established normal human fibroblast (hPF) clones retaining non-integrating human artificial chromosome (HAC) vectors harboring the hTERT expression cassette. In hTERT-HAC/hPF clones, we observed the telomerase activity and the suppression of senescent-associated SA-beta-galactosidase activity. Furthermore, the hTERT-HAC/hPF clones continued growing beyond 120days after cloning, whereas the hPF clones retaining the silent hTERT-HAC senesced within 70days. Thus, hTERT-HAC-mediated episomal expression of hTERT allows the extension of the life-span of human primary cells, implying that gene delivery by non-integrating HAC vectors can be used to control cellular proliferative capacity of primary cultured cells.


Subject(s)
Cell Proliferation , Chromosomes, Artificial, Human/genetics , Genetic Vectors/genetics , Telomerase/genetics , Animals , CHO Cells , Cell Division , Cellular Senescence , Cricetinae , Cricetulus , Fibroblasts/enzymology , Fibroblasts/physiology , Gene Transfer Techniques , Humans , Telomerase/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...